Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Schlumberger
SLB
|
+$527M |
| 2 |
Qualcomm
QCOM
|
+$448M |
| 3 |
Marriott International Class A Common Stock
MAR
|
+$369M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$305M |
| 5 |
CELG
Celgene Corp
CELG
|
+$230M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
+$1.05B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$543M |
| 3 |
Goldman Sachs
GS
|
+$496M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$452M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| 1 | Healthcare | 18.05% |
| 2 | Consumer Discretionary | 14.25% |
| 3 | Technology | 11.26% |
| 4 | Communication Services | 11.22% |
| 5 | Energy | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFM
451
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $13.9M | 0.01% |
415,457
-134
| -0% | -$4.49K |
|
452
Douglas Emmett
DEI
$2.75B
| $13.9M | 0.01% |
491,050
-26,542
| -5% | -$749K |
|
453
Robert Half
RHI
$3.56B
| $13.6M | 0.01% |
+284,812
| New | +$13.6M |
|
|
CMRX
454
DELISTED
Chimerix, Inc.
CMRX
| $13.5M | 0.01% |
616,822
-44,465
| -7% | -$976K |
|
|
DSCI
455
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $13.3M | 0.01% |
1,147,940
-123,981
| -10% | -$1.43M |
|
|
MLU
456
DELISTED
METLIFE, INC. COM EQUITY UNIT
MLU
| $13.2M | 0.01% |
413,000
| – | – |
|
|
PFPT
457
DELISTED
Proofpoint, Inc.
PFPT
| $13.1M | 0.01% |
350,031
+38,029
| +12% | +$1.42M |
|
458
MPLX
MPLX
$50.8B
| $12.5M | 0.01% |
193,835
-7,334
| -4% | -$473K |
|
|
I.PRA
459
DELISTED
INTELSAT S A MANDATORY CONV JR NON VTG PFD SHS (LUX)
I.PRA
| $12.3M | 0.01% |
242,300
| – | – |
|
|
AVDL
460
Avadel Pharmaceuticals
AVDL
$1.54B
| $12.3M | 0.01% |
819,787
-680,213
| -45% | -$10.2M |
|
461
Marcus & Millichap
MMI
$1.26B
| $11.9M | 0.01% |
467,773
+21,266
| +5% | +$543K |
|
462
Asbury Automotive
ABG
$4.86B
| $11.9M | 0.01% |
172,727
-34,183
| -17% | -$2.35M |
|
|
FLXN
463
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $11.1M | 0.01% |
820,677
+90,878
| +12% | +$1.23M |
|
|
FCSC
464
DELISTED
Fibrocell Science Inc.
FCSC
| $11M | 0.01% |
184,151
-13,139
| -7% | -$786K |
|
465
Agios Pharmaceuticals
AGIO
$2.07B
| $10.9M | 0.01% |
237,239
-72,168
| -23% | -$3.31M |
|
466
Arrowhead Research
ARWR
$3.99B
| $10.7M | 0.01% |
746,366
-30,380
| -4% | -$435K |
|
467
Tractor Supply
TSCO
$31B
| $10.4M | 0.01% |
860,120
-3,538,790
| -80% | -$42.7M |
|
468
Icon
ICLR
$12.9B
| $10.2M | 0.01% |
217,381
-500,043
| -70% | -$23.6M |
|
469
Ultragenyx Pharmaceutical
RARE
$3.02B
| $9.79M | 0.01% |
218,161
-65,059
| -23% | -$2.92M |
|
|
PE
470
DELISTED
PARSLEY ENERGY INC
PE
| $9.65M | 0.01% |
+401,018
| New | +$9.65M |
|
471
G-III Apparel Group
GIII
$1.13B
| $9.51M | 0.01% |
232,998
+200,008
| +606% | +$8.17M |
|
|
PLG
472
Platinum Group Metals
PLG
$185M
| $8.77M | 0.01% |
73,661
| – | – |
|
473
NN Inc
NNBR
$121M
| $8.74M | 0.01% |
341,614
+253,985
| +290% | +$6.5M |
|
|
TTPH
474
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $8.73M | 0.01% |
32,357
-3,940
| -11% | -$1.06M |
|
475
Qualys
QLYS
$4.75B
| $8.31M | 0.01% |
323,777
+1,663
| +0.5% | +$42.7K |
|